Powerful against COVID-19, gentle on you
NUVAXOVID is a vaccine to protect against COVID-19 for people who are:
-
65 years of age and older, or
-
12 years through 64 years of age at high risk for severe COVID-19
Vaccination with NUVAXOVID may not protect all people who receive the vaccine.
NUVAXOVID does not contain SARS-CoV-2, the virus that causes COVID-19. NUVAXOVID cannot give you or your child COVID-19.
NUVAXOVID is the only non-mRNA, recombinant protein-based COVID-19 vaccine
Here's why that matters to you.
Concerned about COVID-19 vaccine side effects?
You want the protection of an updated COVID-19 vaccine, because you know that COVID-19 is still a serious threat. But dealing with side effects that may disrupt your life might make you think twice about getting vaccinated.
NUVAXOVID may help. It’s the only non-mRNA, recombinant protein-based COVID-19 vaccine made in the same tried-and-true approach that's been widely used in certain flu vaccines.
It doesn't matter which COVID-19 shot you've had before—you can get NUVAXOVID as your next one
In a clinical study, NUVAXOVID provided:
-
~90% effectiveness in protecting against illness from COVID-19
-
100% protection against severe COVID-19 and hospitalization*
*Although not part of the pre-planned analysis, this observation was made after the trial was completed.
- Convenient to get at the same time as your flu shot
- Regardless of which COVID-19 vaccine you have received in past seasons, you can get Nuvaxovid if you're eligible
How to pronounce NUVAXOVID
Nu-vax-oh-vid.
Make sure you get what you ask for. Ask your pharmacist or doctor for NUVAXOVID by name.
Talk to your pharmacist or doctor about NUVAXOVID, the only non-mRNA, recombinant protein-based COVID-19 vaccine
Important Safety Information
You or your child should not get NUVAXOVID if you had a severe allergic reaction to a previous dose of NUVAXOVID or to any of its ingredients.
There is a remote chance that the vaccine could cause a severe allergic reaction, which would usually occur within a few minutes to one hour after getting a dose. For this reason, the vaccination provider may ask you or your child to stay at the place where you or your child received the vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include: difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body and/or dizziness and weakness
Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received NUVAXOVID. The chance of having this occur is very low. You should seek medical attention right away if you or your child have any of the following symptoms after receiving the vaccine: chest pain; shortness of breath; feelings of having a fast-beating, fluttering, or pounding heart.
Other side effects reported in clinical trials and/or post-approval use of NUVAXOVID include: Injection site reactions (pain/tenderness, swelling, redness and itching), fatigue or generally feeling unwell, muscle pain, headache, joint pain, nausea, vomiting, fever, chills, allergic reactions such as hives and swelling of the face, swollen lymph nodes, paresthesia (unusual feeling in the skin such as tingling or a crawling feeling), and hypoesthesia (decreased feeling or sensitivity, especially in the skin)
Indication
NUVAXOVID is a vaccine to protect against COVID-19 for people who are:
- 65 years of age and older, or
- 12 years through 64 years of age at high risk for severe COVID-19
Vaccination with NUVAXOVID may not protect all people who receive the vaccine.
NUVAXOVID does not contain SARS-CoV-2, the virus that causes COVID-19. NUVAXOVID cannot give you or your child COVID-19.
Learn more about Sanofi's commitment to fighting counterfeit drugs.
Important Safety Information
You or your child should not get NUVAXOVID if you had a severe allergic reaction to a previous dose of NUVAXOVID or to any of its ingredients.
There is a remote chance that the vaccine could cause a severe allergic reaction, which would usually occur within a few minutes to one hour after getting a dose. For this reason, the vaccination provider may ask you or your child to stay at the place where you or your child received the vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include: difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body and/or dizziness and weakness
Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received NUVAXOVID. The chance of having this occur is very low. You should seek medical attention right away if you or your child have any of the following symptoms after receiving the vaccine: chest pain; shortness of breath; feelings of having a fast-beating, fluttering, or pounding heart.
Other side effects reported in clinical trials and/or post-approval use of NUVAXOVID include: Injection site reactions (pain/tenderness, swelling, redness and itching), fatigue or generally feeling unwell, muscle pain, headache, joint pain, nausea, vomiting, fever, chills, allergic reactions such as hives and swelling of the face, swollen lymph nodes, paresthesia (unusual feeling in the skin such as tingling or a crawling feeling), and hypoesthesia (decreased feeling or sensitivity, especially in the skin)
Indication
NUVAXOVID is a vaccine to protect against COVID-19 for people who are:
- 65 years of age and older, or
- 12 years through 64 years of age at high risk for severe COVID-19
Vaccination with NUVAXOVID may not protect all people who receive the vaccine.
NUVAXOVID does not contain SARS-CoV-2, the virus that causes COVID-19. NUVAXOVID cannot give you or your child COVID-19.
Learn more about Sanofi's commitment to fighting counterfeit drugs.
Important Safety Information
You or your child should not get NUVAXOVID if you had a severe allergic reaction to a previous dose of NUVAXOVID or to any of its ingredients.
There is a remote chance that the vaccine could cause a severe allergic reaction, which would usually occur within a few minutes to one hour after getting a dose. For this reason, the vaccination provider may ask you or your child to stay at the place where you or your child received the vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include: difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body and/or dizziness and weakness
Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received NUVAXOVID. The chance of having this occur is very low. You should seek medical attention right away if you or your child have any of the following symptoms after receiving the vaccine: chest pain; shortness of breath; feelings of having a fast-beating, fluttering, or pounding heart.
Other side effects reported in clinical trials and/or post-approval use of NUVAXOVID include: Injection site reactions (pain/tenderness, swelling, redness and itching), fatigue or generally feeling unwell, muscle pain, headache, joint pain, nausea, vomiting, fever, chills, allergic reactions such as hives and swelling of the face, swollen lymph nodes, paresthesia (unusual feeling in the skin such as tingling or a crawling feeling), and hypoesthesia (decreased feeling or sensitivity, especially in the skin)
Indication
NUVAXOVID is a vaccine to protect against COVID-19 for people who are:
- 65 years of age and older, or
- 12 years through 64 years of age at high risk for severe COVID-19
Vaccination with NUVAXOVID may not protect all people who receive the vaccine.
NUVAXOVID does not contain SARS-CoV-2, the virus that causes COVID-19. NUVAXOVID cannot give you or your child COVID-19.
Learn more about Sanofi's commitment to fighting counterfeit drugs.